Browse Data and Analysis

On July 26, 2016, Côte d’Ivoire enacted its national Biosafety Law No. 2016-553. This law establishes the groundwork for managing genetically engineered (GE) products.

Bangladesh is pursuing advanced biotechnological crop research. In June 2023, the Bangladesh Academy of Science submitted a “Standard Operating Procedures for Research and Release of Genome Edited Plants of Categories SDN-1 and SDN-2 in Bangladesh”...

The push for the move toward biotechnology in Cote d'Ivoire began in June of 2015, when the government of Cote d'Ivoire (GOCI) adopted and ratified the Cartagena Protocol.

The Government of Bangladesh has demonstrated a willingness to adopt and implement a modern agricultural policy framework and guidelines which support the safe and appropriate use of science and technology, including biotechnology, to help meet agricultural challenges.

On July 26, 2016, Cote d’Ivoire announced the implementation of the national biosafety law after its adoption by parliament. Although the country is in the early stages of adopting agricultural biotechnology, its biosafety law is the foundation on which the country will manage the approval processes, risk management, containment, and labelling for genetically engineered (GE) products developed domestically or by a third country.

The Government of Bangladesh has demonstrated a willingness to adopt and implement a modern agricultural policy framework and guidelines which support the safe and appropriate use of science and technology, including biotechnology, to address the...

While still in the early stages for adopting genetically engineered products, the Government of Cote d’Ivoire is putting systems in place to eventually allow GE products onto the market.

The Government of Bangladesh has demonstrated a willingness to adopt and implement modern agricultural policy frameworks and guidelines that supports the safe and appropriate use of science...

Bangladesh is a role model of acceptance and advancement of modern agricultural biotechnology.

Bangladesh is a role model of acceptance and advancement of modern biotech in daily life.

The modern biotech sector in Bangladesh is advancing moderately through research on several crops with support from policymakers, regulators and development partners.

On July, 26, 2016, The President of Cote d’Ivoire announced the implementation of the national biosafety law adopted by the parliament on July 1, 2016.